By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


SAGE Therapeutics 

29 Newbury Street

Boston  Massachusetts  02116  U.S.A.
Phone: n/a Fax: n/a



Start Up

Company News
SAGE Therapeutics (SAGE) Announces First Patient Treated In Phase III STATUS Trial Of SAGE-547 In Super-Refractory Status Epilepticus 8/17/2015 5:58:29 AM
SAGE Therapeutics (SAGE) Announces Second Quarter 2015 Financial Results And Highlights Recent Progress 8/12/2015 12:52:22 PM
SAGE Therapeutics (SAGE) Receives Special Protocol Assessment For Phase III STATUS Trial Of SAGE-547 In Super-Refractory Status Epilepticus 8/6/2015 7:30:33 AM
SAGE Therapeutics (SAGE) To Present At The Canaccord Genuity 35th Annual Growth Conference 8/5/2015 11:05:49 AM
SAGE Therapeutics (SAGE) Announces Positive Top-Line Data In Exploratory Trial Of SAGE-547 In Postpartum Depression 6/9/2015 7:52:34 AM
SAGE Therapeutics (SAGE) Soars as Postpartum Depression Disappears in Four New Mothers 6/9/2015 6:22:39 AM
SAGE Therapeutics To Participate In The Goldman, Sachs & Co. 36th Annual Global Healthcare Conference 6/3/2015 12:49:54 PM
SAGE Therapeutics Announces SAGE-547 Progress And First Quarter 2015 Financial Results 5/14/2015 1:24:32 PM
SAGE Therapeutics Elated as Brain Seizure Drug Shows 77% Response Rate 5/14/2015 6:01:37 AM
SAGE Therapeutics To Present At UBS Global Healthcare Conference 5/12/2015 10:25:37 AM